Stryker Corporation (SYK)

Stryker Corp.'s stock price was significantly impacted by a cyberattack in March 2026, disrupting operations and causing delays in revenue recognition. The company missed Q1 2026 revenue and earnings expectations, leading to a stock drop. Acquisitions of Nico Corporation in 2024 and Inari Medical boosted the neurovascular business. Over the past 30 days, SYK stock has dropped by about 10%, and it is down 25.36% over the past 12 months.

Stryker Corp. experiences demand seasonality for its products and services. The company's Q1 earnings call transcript for 2026 mentioned "normal quarter seasonal cash outflows" in the first quarter. The company anticipates that the latter half of the year typically sees a recovery or specific seasonal patterns in demand.

Stryker Corporation is a global medical technology company focusing on MedSurg, Neurotechnology, and Orthopaedics. It designs, manufactures, and markets medical equipment, instruments, consumable supplies, and implantable devices. Key products include implants for joint replacements, surgical equipment, surgical navigation systems, neurosurgical equipment, and spinal implant systems. The company is also known for its orthopedic robotics, like the Mako SmartRobotics platform.

Stryker Corp. has a significant global presence, selling its products in over 75 countries. The United States is the primary revenue driver, accounting for approximately 75% of revenues. International markets contribute the remaining 20-25% of total sales. Stryker operates in four main regions: the United States, Europe, Middle East, Africa (EMEA), Asia Pacific, and Other countries. In fiscal year 2025, EMEA generated $3.18 billion in revenue, and Asia Pacific generated $2.16 billion.

Stryker Corp.'s brand reputation has been affected by a cyberattack in March 2026, which led to operational disruptions and delayed surgeries. In 2022, Stryker was categorized by the Yale School of Management in the "Grade F" category for continuing business in Russia, potentially impacting its reputation among stakeholders concerned with corporate social responsibility.

Stryker Corp.'s ownership is primarily held by institutional investors, who collectively control approximately 78-79% of outstanding shares. Major institutional shareholders include The Vanguard Group, Inc., BlackRock, Inc., State Street Corporation, Greenleaf Trust, J.P. Morgan Asset Management, T. Rowe Price Associates, Geode Capital Management, LLC, Wellington Management Group LLP, and AllianceBernstein L.P. Significant individual stakes are held by family members, including John W. Brown and Ronda Stryker.